IP Library Granted Patent US 9,228,229
Granted Patent B2
US 9,228,229 · App. 13/796,901 · Granted Jan 5, 2016

Digital analyte analysis

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,228,229
App. No.
13/796,901
Granted
Jan 5, 2016
Kind
B2
Abstract

The invention generally relates to droplet based digital PCR and methods for analyzing a target nucleic acid using the same. In certain embodiments, methods of the invention involve forming sample droplets containing, on average, a single target nucleic acid, amplifying the target in the droplets, excluding droplets containing amplicon from the target and amplicon from a variant of the target, and analyzing target amplicons.

Claims (14)

1. A method for analyzing a nucleic acid template in a biological sample, the method comprising the steps of:

forming a plurality of microdroplets, each comprising a nucleic acid template and a plurality of sets of primer pairs, each set of primer pairs being specific for a different target site on a different nucleic acid template, binding only a single primer pair to the target site on the nucleic acid template in each microdroplet;

amplifying a single target site from the nucleic acid template in each of the microdroplets using one of the sets of primer pairs specific for the single target site to generate amplification products;

attaching a sequencing adaptor and a barcode sequence to the amplification products; and

sequencing the amplification products, thereby to analyze the nucleic acid template.

2. The method according to claim 1 , wherein the amplification products are attached to a bead.

3. The method according to claim 2 , wherein the amplification products are attached to a surface.

4. The method according to claim 3 , wherein the surface is a surface of a flow cell.

5. The method according to claim 3 , wherein the amplification products are covalently attached to the surface.

6. The method according to claim 1 , wherein sequencing is sequencing-by-synthesis.

7. The method according to claim 6 , wherein sequencing-by-synthesis is single-molecule sequencing-by-synthesis.

8. The method according to claim 1 , wherein amplifying is by the polymerase chain reaction.

9. The method according to claim 1 , wherein the single nucleic acid template is a DNA or an RNA.

10. The method according to claim 1 , wherein the nucleic acid template is associated with a cancer.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 7, 2019
From: RAINDANCE TECHNOLOGIES, INC.
To: BIO-RAD LABORATORIES, INC.
Reel/Frame 049109/0498 →
RELEASE OF SECURITY INTEREST Recorded Feb 17, 2017
From: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II (CAYMAN) L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.; CRG ISSUER 2015-1
To: RAINDANCE TECHNOLOGIES, INC.
Reel/Frame 041290/0585 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 4, 2014
From: OLSON, JEFFREY, MR.; LINK, DARREN R., MR.
To: RAINDANCE TECHNOLOGIES, INC.
Reel/Frame 032607/0391 →
SHORT-FORM PATENT SECURITY AGREEMENT Recorded Sep 17, 2013
From: RAINDANCE TECHNOLOGIES, INC.
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
Reel/Frame 031267/0376 →